Schweiger Dermatology
Latest Content
Please check back later for more content.
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
World Cancer Day 2026: La Roche-Posay and ONS Partner to Launch Skin of Color Toxicity Repository
4
Sagimet and Ascletis Report Positive 52-Week Safety and Efficacy Data for Denifanstat in Acne
5